Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
HIV Med ; 5 Suppl 2: 46-60, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15239716

RESUMO

The widespread use of highly active antiretroviral therapy (HAART) has dramatically reduced HIV-associated morbidity and mortality where treatment has been made available. Very high levels of adherence to HAART are a prerequisite for a successful virological and immunological response. Low adherence increases the risk of treatment failure and disease progression. It is also likely to lead to further transmission of resistant viruses, and to have a negative impact on the cost effectiveness of HAART. Low adherence is difficult to predict, and this has two key implications for service provision. Firstly, HAART should not be withheld on the basis of assumptions about adherence. Secondly, support with adherence should be provided to all patients prescribed HAART. Our understanding of barriers to and enablers of high adherence, and the evidence base regarding effective interventions, is limited. Meta-analysis of randomized controlled trials available from the general literature suggests multiple interventions are required to maintain high adherence to chronic therapy. This document recommends a series of measures for adoption within HIV clinical care settings, based on evaluation of existing data. High adherence is a process, not a single event, and therefore adherence support must be integrated into clinical follow up. Every prescribing unit should have a written policy on provision of adherence support, and ensure that staff are appropriately trained to make delivery of such services possible.


Assuntos
Fármacos Anti-HIV/uso terapêutico , Infecções por HIV/tratamento farmacológico , Cooperação do Paciente , Apoio Social , Terapia Antirretroviral de Alta Atividade , Infecções por HIV/psicologia , Humanos , Reino Unido
2.
G Ital Dermatol Venereol ; 125(11): 527-32, 1990 Nov.
Artigo em Italiano | MEDLINE | ID: mdl-2150957

RESUMO

Keratosis punctata palmaris et plantaris (KPPP) of Buschke-Fischer-Brauer is an autosomal dominant genodermatosis characterized by disseminated cup-shaped horny papules with central depression containing keratotic plugs. The disease is circumscribed on the palms and soles; associated abnormalities are unusual. The microscopic findings show normal structure of the epidermis with massive orthokeratotic hyperkeratosis, hypergranulosis and acanthosis; dermis is slightly compressed below the epidermis level by the keratotic plugs and free of inflammatory infiltrates. We describe a female of 37 years old (proband) affected by KPPP and her familiar pedigree showing that dermatosis is dominantly inherited. The clinical features of KPPP are like the first reports of Brauer (keratoderma dissipatum hereditarium palmoplantare). The criteria used to diagnose and classify the hereditary palmoplantar keratoderma are also discussed.


Assuntos
Ceratodermia Palmar e Plantar/genética , Adolescente , Adulto , Feminino , Humanos , Ceratodermia Palmar e Plantar/patologia , Masculino , Pessoa de Meia-Idade , Linhagem , Síndrome
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...